Last update 28 Feb 2026

5-HT2A agonists-126(Smith, Gambrell & Russell LLP)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
5-HT2A receptor
Action
agonists
Mechanism
5-HT2A receptor agonists(Serotonin 2a (5-HT2a) receptor agonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
AlcoholismDepressive DisorderNeuralgia+ [2]
Inactive Indication-
Originator Organization
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
Active Organization
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC23H25NO2
InChIKeyGSQUMYYKWCMAAV-UHFFFAOYSA-N
CAS Registry2952978-73-1

Related

100 Clinical Results associated with 5-HT2A agonists-126(Smith, Gambrell & Russell LLP)
Login to view more data
100 Translational Medicine associated with 5-HT2A agonists-126(Smith, Gambrell & Russell LLP)
Login to view more data
100 Patents (Medical) associated with 5-HT2A agonists-126(Smith, Gambrell & Russell LLP)
Login to view more data
1
Literatures (Medical) associated with 5-HT2A agonists-126(Smith, Gambrell & Russell LLP)
ACS Medicinal Chemistry Letters
Novel Phenethylamines as 5-HT2A Agonists for Treating Depression, Drug Addiction, Alcoholism, PTSD, and Neuropathic Pain
100 Deals associated with 5-HT2A agonists-126(Smith, Gambrell & Russell LLP)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AlcoholismPreclinical
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
02 Jul 2025
Depressive DisorderPreclinical
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
02 Jul 2025
NeuralgiaPreclinical
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
02 Jul 2025
Stress Disorders, Post-TraumaticPreclinical
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
02 Jul 2025
Unspecified drug dependencePreclinical
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
02 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free